Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Pinder

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Journal of Affective Disorders|September 1, 1982
Monoamine metabolites in cerebrospinal fluid of depressed patients during treatment with mianserin or amitriptylineJ Mendlewicz, R M Pinder, S M Stulemeijer, et al.
Drugs|March 1, 1977
Doxepin up-to-date: a review of its pharmacological properties and therapeutic efficacy with particular reference to depressionR M Pinder, R N Brogden, T M Speight, et al.
Drugs|November 1, 1976
Clonazepam: a review of its pharmacological properties and therapeutic efficacy in epilepsyR M Pinder, R N Brogden, T M Speight, et al.
Drugs|January 1, 1977
Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticityR M Pinder, R N Brogden, T M Speight, et al.
Journal of Medicinal Chemistry|September 1, 1971
2-Aminoindan-2-carboxylic acids. Potential tyrosine hydroxylase inhibitorsR M Pinder, B H Butcher, D A Buxton, et al.
Drugs|July 1, 1977
Hexoprenaline: a review of its pharmacological properties and therapeutic efficacy with particular reference to asthmaR M Pinder, R N Brogden, T M Speight, et al.
Drugs|May 1, 1977
Maprotiline: a review of its pharmacological properties and therapeutic efficacy in mental depressive statesR M Pinder, R N Brogden, T M Speight, et al.
Drugs|February 1, 1977
Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsyR M Pinder, R N Brogden, T M Speight, et al.
Drugs|June 1, 1977
Viloxazine: a review of its pharmacological properties and therapeutic efficacy in depressive illnessR M Pinder, R N Brogden, T M Speight, et al.
Drugs|August 1, 1977
Rimiterol: a review of its pharmacological properties and therapeutic efficacy in asthmaR M Pinder, R N Brogden, T M Speight, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Journal of Affective Disorders|September 1, 1982
Monoamine metabolites in cerebrospinal fluid of depressed patients during treatment with mianserin or amitriptylineJ Mendlewicz, R M Pinder, S M Stulemeijer, et al.
Drugs|March 1, 1977
Doxepin up-to-date: a review of its pharmacological properties and therapeutic efficacy with particular reference to depressionR M Pinder, R N Brogden, T M Speight, et al.
Drugs|November 1, 1976
Clonazepam: a review of its pharmacological properties and therapeutic efficacy in epilepsyR M Pinder, R N Brogden, T M Speight, et al.
Drugs|January 1, 1977
Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticityR M Pinder, R N Brogden, T M Speight, et al.
Journal of Medicinal Chemistry|September 1, 1971
2-Aminoindan-2-carboxylic acids. Potential tyrosine hydroxylase inhibitorsR M Pinder, B H Butcher, D A Buxton, et al.
Drugs|July 1, 1977
Hexoprenaline: a review of its pharmacological properties and therapeutic efficacy with particular reference to asthmaR M Pinder, R N Brogden, T M Speight, et al.
Drugs|May 1, 1977
Maprotiline: a review of its pharmacological properties and therapeutic efficacy in mental depressive statesR M Pinder, R N Brogden, T M Speight, et al.
Drugs|February 1, 1977
Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsyR M Pinder, R N Brogden, T M Speight, et al.
Drugs|June 1, 1977
Viloxazine: a review of its pharmacological properties and therapeutic efficacy in depressive illnessR M Pinder, R N Brogden, T M Speight, et al.
Drugs|August 1, 1977
Rimiterol: a review of its pharmacological properties and therapeutic efficacy in asthmaR M Pinder, R N Brogden, T M Speight, et al.
Pageof 8